Cytosorbents (CTSO) vs Pulsenmore (PLSM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Pulsenmore is the larger company by market cap ($12.5 million vs $11.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTSO | PLSM |
|---|---|---|
| Share price | $3.73 | $1.92 |
| Market cap | $11.75M | $12.49M |
| 1-day change | -3.62% | +0.73% |
| YTD return | -70.81% | — |
| 1-year return | -80.87% | — |
| 5-year return | -96.82% | — |
| EPS (TTM) | $-5.80 | $-1.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.72 | $12.97 |
| 52-week low | $3.66 | $1.82 |
| Distance from 52-week high | -81.09% | -85.20% |
| Analyst consensus | none | — |
| Avg. price target upside | +1173.46% | — |
| Average volume | 12.45K | 470.76K |
| Shares outstanding | 3.15M | 6.50M |
| Employees | 129 | 71 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cytosorbents
CTSO stock →Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and inflammatory mediators and blood thinners in cardiac surgery applications, as well as to remove antithrombotic drugs and inflammatory mediators in cardiothoracic surgery applications.
Healthcare · Medical Devices · 129 employees
About Pulsenmore
PLSM stock →Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products in the United States, the United Kingdom, Northern Ireland, and Europe.
Healthcare · Medical Devices · 71 employees
CTSO vs PLSM FAQ
Which is bigger, Cytosorbents or Pulsenmore?
Pulsenmore (PLSM) is larger, with a market capitalization of $12.49M compared with $11.75M for Cytosorbents (CTSO).
Are Cytosorbents and Pulsenmore in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.